Screener
Thermo Fisher Scientific TMO Life Sciences Solutions — Purchases of property, plant and equipment
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Thermo Fisher Scientific in its filing.
Tagged under the XBRL concept us-gaap:SegmentExpenditureAdditionToLongLivedAssets.
The source filing: Thermo Fisher Scientific’s 10-Q, filed May 1, 2026.
- Filed
- May 1, 2026, 11:00 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0000097745-26-000092
| (In millions) | Unallocated amounts | Life Sciences Solutions | Analytical Instruments | Specialty Diagnostics | Laboratory Products and Biopharma Services | Consolidated |
|---|---|---|---|---|---|---|
| Segment assets | $98,434 | $3,490 | $3,104 | $1,332 | $6,921 | $113,281 |
| Purchases of property, plant and equipment | 28 | 20 | 36 | 35 | 259 | 376 |
| Depreciation of property, plant and equipment | — | 70 | 26 | 24 | 186 | 306 |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Thermo Fisher Scientific's life sciences solutions — purchases of property, plant and equipment?
- Thermo Fisher Scientific (TMO) reported life sciences solutions — purchases of property, plant and equipment of $20M in Q1 2026.
- How has Thermo Fisher Scientific's life sciences solutions — purchases of property, plant and equipment changed year-over-year?
- Thermo Fisher Scientific's life sciences solutions — purchases of property, plant and equipment decreased by 53.5% year-over-year, from $43M to $20M.
- What is the long-term trend for Thermo Fisher Scientific's life sciences solutions — purchases of property, plant and equipment?
- Over 3 years (2021 to 2025), Thermo Fisher Scientific's life sciences solutions — purchases of property, plant and equipment has grown at a -42.7% compound annual growth rate (CAGR), from $810M to $152M.
- What does life sciences solutions — purchases of property, plant and equipment mean?
- This metric measures the cash outflows for capital expenditures specifically directed toward the Life Sciences Solutions segment. It reflects investments in new manufacturing capacity, laboratory equipment, and facility upgrades necessary to maintain competitive production capabilities. Tracking these expenditures provides insight into the segment's growth strategy and its commitment to long-term operational capacity.
Ask your AI about Thermo Fisher Scientific's life sciences solutions — purchases of property, plant and equipment.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI

Claude